As per the latest Enforcement Report of the US Food and Drug Administration (USFDA), the Mumbai-based company is recalling Cefdinir for oral suspension USP, 250 mg/5mL, packaged in 60 ml bottles.from Moneycontrol Business News https://ift.tt/2Xl2Rbw
No comments:
Post a Comment